{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:03:49Z","timestamp":1781201029359,"version":"3.54.1"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Because neurodegenerative diseases such as Parkinson\u2019s and Alzheimer\u2019s Diseases [AD and PD] as well as the progressive forms of multiple sclerosis [MS] are invariably associated with clinically significant cortical symptoms such as language difficulties, motor skill deficits and cognitive impairments, especially memory, a tacit assumption evolved that visual disorders related to cortical dysfunction must localize only to the temporal, parietal and occipital lobes. Based upon our current understanding, retinal changes in MS are most likely secondary to optic neuropathy, whereas in AD and PD, they appear to represent primary retinal changes. The paradigm was reinforced by the lack of retinal findings using ophthalmoscopy. Spectral domain optical coherence tomography [OCT], optical coherence angiography [OCT-A], and fundus autofluorescence [FAF] have challenged this creed by uncovering structural changes within the retina over and above what can occur as a consequence of optic neuropathy in the case of MS. Still, definitive diagnostic and prognostic data have yet to emerge. Fluorescence lifetime imaging ophthalmoscopy [FLIO], a non-invasive, non-contact, painless imaging technology, measures nanosecond lifetimes of endogenous retinal fluorophores, some of which are linked to mitochondrial activity. Therefore, FLIO is a metabolic, not a structural imaging modality. Because mitochondrial dysfunction occurs in many neurodegenerative diseases, FLIO offers a unique strategy for investigating retinal metabolism in AD, PD, and MS. This article reviews the basic biomedical engineering of FLIO and reports preliminary data from these diseases, correlated with disease duration. These functional\n                    <jats:italic>in vivo<\/jats:italic>\n                    data are consistent with retinal metabolic changes in AD, PD, and progressive MS that were\n                    <jats:italic>\u201chiding in plain sight\u201d<\/jats:italic>\n                    from structural examinations.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2025.1659264","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:13:03Z","timestamp":1761192783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Fluorescence lifetime imaging ophthalmoscopy adds the retina to cortical pathology for visual dysfunction in neurodegenerative diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Jirat","family":"Nimworaphan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Sergott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2047-9158-1-5","article-title":"Neuroimaging in the early diagnosis of neurodegenerative disease","volume":"1","author":"Stoessl","year":"2012","journal-title":"Transl Neurodegener"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fneur.2018.00265","article-title":"Role of neuroimaging as a biomarker for neurodegenerative diseases","volume":"9","author":"Shimizu","year":"2018","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e230173","DOI":"10.1148\/radiol.230173","article-title":"Neuroimaging in dementia: more than typical Alzheimer disease","volume":"308","author":"Haller","year":"2023","journal-title":"Radiology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102230","DOI":"10.1016\/j.arr.2024.102230","article-title":"Unveiling the future: advancements in MRI imaging for neurodegenerative disorders","volume":"95","author":"Du","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-022-01358-6","article-title":"Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging","volume":"14","author":"Loftus","year":"2023","journal-title":"Insights Imaging"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-150457","article-title":"Retinal oximetry imaging in Alzheimer's disease","volume":"49","author":"Einarsdottir","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajo.2020.04.040","article-title":"Retinal biomarkers of Alzheimer disease","volume":"218","author":"Lee","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/biom11081215","article-title":"Retinal dysfunction in Alzheimer\u2019s disease and implications for biomarkers","volume":"11","author":"Liao","year":"2021","journal-title":"Biomolecules"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/cns.13963","article-title":"Machine learning based on optical coherence tomography images as a diagnostic tool for Alzheimer's disease","volume":"28","author":"Wang","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3233\/JAD-220596","article-title":"Retinal examinations provides early warning of Alzheimer's disease","volume":"90","author":"Xia","year":"2022","journal-title":"J Alzheimer's Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.dadm.2018.01.003","article-title":"Change in retinal structural anatomy during the preclinical stage of Alzheimer\u2019s disease","volume":"10","author":"Santos","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","article-title":"Spectral-domain OCT measurements in Alzheimer's disease: a systematic review and Meta-analysis","volume":"126","author":"Chan","year":"2019","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/WNO.0000000000001140","article-title":"Retinal microvascular alterations as the biomarkers for Alzheimer disease: are we there yet?","volume":"41","author":"Jiang","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WNO.0000000000000580","article-title":"Altered macular microvasculature in mild cognitive impairment and Alzheimer disease","volume":"38","author":"Jiang","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1111\/ene.14871","article-title":"Novel noninvasive biomarkers of prodromal Alzheimer disease: the role of optical coherence tomography and optical coherence tomography-angiography","volume":"28","author":"Biscetti","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/jamaophthalmol.2021.0319","article-title":"Structural and functional retinal changes in preclinical Alzheimer disease","volume":"139","author":"Grewal","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"731614","DOI":"10.3389\/fnins.2021.731614","article-title":"Retinal vasculopathy in Alzheimer\u2019s disease","volume":"15","author":"Shi","year":"2021","journal-title":"Front Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1101950","DOI":"10.3389\/fnagi.2023.1101950","article-title":"A cross-sectional study of retinal vessel changes based on optical coherence tomography angiography in Alzheimer's disease and mild cognitive impairment","volume":"15","author":"Ma","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/bjo-2022-321399","article-title":"Deep segmentation of OCTA for evaluation and association of changes of retinal microvasculature with Alzheimer\u2019s disease and mild cognitive impairment","volume":"108","author":"Xie","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/JAD-200175","article-title":"Cerebrospinal fluid and MRI biomarkers in neurodegenerative diseases: a retrospective memory clinic-based study","volume":"75","author":"Kaipainen","year":"2020","journal-title":"J Alzheimer's Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s13311-023-01379-z","article-title":"Fluid and biopsy based biomarkers in Parkinson's disease","volume":"20","author":"Coughlin","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neurol.2022.09.003","article-title":"Overview of the blood biomarkers in Alzheimer's disease: promises and challenges","volume":"179","author":"Delaby","year":"2023","journal-title":"Rev Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer's Res Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"117848","DOI":"10.1016\/j.cca.2024.117848","article-title":"Cerebrospinal fluid protein biomarkers in Parkinson's disease","volume":"556","author":"Faizan","year":"2024","journal-title":"Clin Chim Acta"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10571-024-01523-z","article-title":"Differences in blood and cerebrospinal fluid between Parkinson's disease and related diseases","volume":"45","author":"Ma","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","article-title":"Brain PET in the diagnosis of Alzheimer's disease","volume":"39","author":"Marcus","year":"2014","journal-title":"Clin Nucl Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cpet.2022.09.006","article-title":"Brain PET imaging: approach to cognitive impairment and dementia","volume":"18","author":"Spano","year":"2023","journal-title":"PET Clin"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e14338","DOI":"10.1002\/alz.14338","article-title":"Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"21","author":"Rabinovici","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1167\/iovs.13-13627","article-title":"Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects","volume":"55","author":"Dysli","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1117\/1.JBO.23.9.091415","article-title":"Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy","volume":"23","author":"Sauer","year":"2018","journal-title":"J Biomed Opt"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1167\/iovs.18-23886","article-title":"Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment","volume":"59","author":"Sauer","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.oret.2017.10.008","article-title":"Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2","volume":"2","author":"Sauer","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41433-019-0406-2","article-title":"A pilot study of fluorescence lifetime imaging ophthalmoscopy in preclinical Alzheimer\u2019s disease","volume":"33","author":"Sadda","year":"2019","journal-title":"Eye"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1364\/BOE.444550","article-title":"Adaptive optics two-photon excited fluorescence lifetime imaging ophthalmoscopy of photoreceptors and retinal pigment epithelium in the living non-human primate eye","volume":"13","author":"Walters","year":"2022","journal-title":"Biomed Opt Express"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/IAE.0000000000002646","article-title":"Fluorescence lifetime imaging ophthalmoscopy (FLIO) patterns in clinically unaffected children of macular telangiectasia type 2 (MACTEL) patients","volume":"40","author":"Sauer","year":"2020","journal-title":"Retina"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/IAE.0000000000002411","article-title":"Fluorescence lifetime patterns in macular telangiectasia type 2","volume":"40","author":"Solberg","year":"2020","journal-title":"Retina"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41433-020-01287-y","article-title":"Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond","volume":"35","author":"Sauer","year":"2021","journal-title":"Eye (Lond)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"S22707","DOI":"10.1117\/1.JBO.29.S2.S22707","article-title":"Multispectral label-free in vivo cellular imaging of human retinal pigment epithelium using adaptive optics fluorescence lifetime ophthalmoscopy improves feasibility for low emission analysis and increases sensitivity for detecting changes with age and eccentricity","volume":"29","author":"Kunala","year":"2024","journal-title":"J Biomed Opt"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/STROKEAHA.107.496091","article-title":"Retinal signs and stroke: revisiting the link between the eye and brain","volume":"39","author":"Baker","year":"2008","journal-title":"Stroke"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-020-00638-x","article-title":"Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases","volume":"12","author":"Lee","year":"2020","journal-title":"Alzheimer's Res Ther"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/IIO.0000000000000549","article-title":"Retinal microstructural and microvascular changes in Alzheimer disease: a review","volume":"65","author":"Olivares Ordo\u00f1ez","year":"2025","journal-title":"Int Ophthalmol Clin"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1493876","DOI":"10.3389\/fneur.2025.1493876","article-title":"Future applications of fluorescence lifetime imaging ophthalmoscopy in neuro-ophthalmology, neurology, and neurodegenerative conditions","volume":"16","author":"Markowitz","year":"2025","journal-title":"Front Neurol"},{"key":"ref46","volume-title":"International congress of Parkinson\u2019s disease and movement disorders; august 28, 2023","author":"Shivok","year":"2023"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/alz.09188038294046","article-title":"Fluorescence lifetime imaging ophthalmoscopy (FLIO), a novel retinal mitochondrial biomarker for Parkinson\u2019s disease","volume":"39","author":"Shivok","year":"2024","journal-title":"Mov Disord"},{"key":"ref48","volume-title":"Fluorescence lifetime imaging ophthalmoscopy (FLIO): A novel retinal metabolic biomarker for multiple sclerosis","author":"Markowitz","year":"2025"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(00)05187-4","article-title":"Some workmen can blame their tools: artistic change in an individual with Alzheimer's disease","volume":"357","author":"Crutch","year":"2001","journal-title":"Lancet"},{"key":"ref50","year":""},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conb.2021.07.007","article-title":"Multimodal retinal imaging to detect and understand Alzheimer\u2019s and Parkinson\u2019s disease","volume":"72","author":"Moons","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1084\/jem.20240386","article-title":"Transport of \u03b2-amyloid from brain to eye causes retinal degeneration in Alzheimer's disease","volume":"221","author":"Cao","year":"2024","journal-title":"J Exp Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.preteyeres.2024.101273","article-title":"Alzheimer's disease pathophysiology in the retina","volume":"101","author":"Gaire","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","article-title":"Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas","volume":"6","author":"Den Haan","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/WCO.0000000000000645","article-title":"Potential retinal biomarkers for dementia: what is new?","volume":"32","author":"Cheung","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2017.01.001","article-title":"Imaging retina to study dementia and stroke","volume":"57","author":"Cheung","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5005\/jp-journals-10028-1238","article-title":"Application of optical coherence tomography in the detection and classification of cognitive decline","volume":"12","author":"Lee","year":"2018","journal-title":"J Curr Glaucoma Pract"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1308345","DOI":"10.3389\/fnins.2023.1308345","article-title":"New insight on microglia activation in neurodegenerative diseases and therapeutics","volume":"17","author":"Xu","year":"2023","journal-title":"Front Neurosci"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","article-title":"Microvascular network alterations in the retina of patients with Alzheimer's disease","volume":"10","author":"Cheung","year":"2014","journal-title":"Alzheimers Dement"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","article-title":"Association of Preclinical Alzheimer Disease with Optical Coherence Tomographic Angiography Findings","volume":"136","author":"O'Bryhim","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","article-title":"Melanopsin retinal ganglion cell loss in Alzheimer disease","volume":"79","author":"La Morgia","year":"2016","journal-title":"Ann Neurol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fneur.2017.00162","article-title":"Retinal ganglion cells and circadian rhythms in Alzheimer\u2019s disease, Parkinson's disease, and beyond","volume":"8","author":"La Morgia","year":"2017","journal-title":"Front Neurol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"106063","DOI":"10.1016\/j.parkreldis.2024.106063","article-title":"Melanopsin retinal ganglion cell function in Alzheimer's vs. Parkinson's disease an exploratory meta-analysis and review of pupillometry protocols","volume":"123","author":"Steiner","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3389\/fneur.2017.00701","article-title":"Optical coherence tomography in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"8","author":"Doustar","year":"2017","journal-title":"Front Neurol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.preteyeres.2020.100899","article-title":"Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances","volume":"82","author":"Gupta","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e12421","DOI":"10.1002\/dad2.12421","article-title":"Retinal imaging biomarkers of Alzheimer's disease: a systematic review and meta-analysis of studies using brain amyloid beta status for case definition","volume":"15","author":"Ashraf","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1167\/iovs.18-24677","article-title":"Human retinal pigment epithelium: in vivo cell morphometry, multispectral autofluorescence, and relationship to cone mosaic","volume":"59","author":"Granger","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"110505","DOI":"10.1117\/1.JBO.20.11.110505","article-title":"Imaging autofluorescence temporal signatures of the human ocular fundus in vivo","volume":"20","author":"Papour","year":"2015","journal-title":"J Biomed Opt"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41433-020-1110-y","article-title":"Functional imaging of mitochondria in retinal diseases using flavoprotein fluorescence","volume":"35","author":"Chen","year":"2021","journal-title":"Eye (Lond)"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e0317354","DOI":"10.1371\/journal.pone.0317354","article-title":"In vivo imaging of mitochondrial function in normal, glaucoma suspect, and glaucoma eyes","volume":"20","author":"Caro","year":"2025","journal-title":"PLoS One"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1172\/JCI154218","article-title":"In vivo imaging of the human eye using a 2-photon-excited fluorescence scanning laser ophthalmoscope","volume":"132","author":"Boguslawski","year":"2022","journal-title":"J Clin Invest"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1364\/BOE.451628","article-title":"Adaptive optics fluorescence lifetime imaging ophthalmoscopy of in vivo human retinal pigment epithelium","volume":"13","author":"Tang","year":"2022","journal-title":"Biomed Opt Express"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.copbio.2004.11.003","article-title":"In vivo molecular and cellular imaging with quantum dots","volume":"16","author":"Gao","year":"2005","journal-title":"Curr Opin Biotechnol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/B978-0-12-374413-5.00357-2","article-title":"Fluorescence theory","volume-title":"Encyclopedia of spectroscopy and spectrometry","author":"Fleming","year":"2010"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"340640","DOI":"10.1016\/j.aca.2022.340640","article-title":"Paper-based optical nanosensors \u2013 a review","volume":"1238","author":"Ghasemi","year":"2023","journal-title":"Anal Chim Acta"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1167\/iovs.66.4.56","article-title":"Fluorescence lifetime imaging ophthalmoscopy, vision, and Chorioretinal asymmetries in aging and age-related macular degeneration: ALSTAR2","volume":"66","author":"Goerdt","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jemt.20427","article-title":"Towards metabolic mapping of the human retina","volume":"70","author":"Schweitzer","year":"2007","journal-title":"Microsc Res Tech"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"e0131640","DOI":"10.1371\/journal.pone.0131640","article-title":"FLIMX: a software package to determine and analyze the fluorescence lifetime in time-resolved fluorescence data from the human eye","volume":"10","author":"Klemm","year":"2015","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"661","DOI":"10.20344\/amp.11978","article-title":"Parkinson's disease: clinical review and update","volume":"32","author":"Cabreira","year":"2019","journal-title":"Acta Medica Port"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson's disease in women and men: what's the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson's disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med Clin North Am"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"617588","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Frontiers in aging","volume":"13","author":"Misrani","year":"2021","journal-title":"Neuroscience"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1484373","DOI":"10.3389\/fimmu.2024.1484373","article-title":"Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","article-title":"Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: a systematic review","volume":"80","author":"M\u00fcller","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamaneurol.2022.4655","article-title":"Association of Early Progression Independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis","volume":"80","author":"Tur","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ana.26913","article-title":"Determinants and biomarkers of progression independent of relapses in multiple sclerosis","volume":"96","author":"Calabrese","year":"2024","journal-title":"Ann Neurol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"e209444","DOI":"10.1212\/WNL.0000000000209444","article-title":"Using the progression independent of relapse activity framework to unveil the pathobiological foundations of multiple sclerosis","volume":"103","author":"Ciccarelli","year":"2024","journal-title":"Neurology"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e207936","DOI":"10.1212\/WNL.0000000000207936","article-title":"Progression independent of relapse activity in multiple sclerosis: closer to solving the pathologic puzzle","volume":"102","author":"Tur","year":"2024","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1659264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:13:05Z","timestamp":1761192785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1659264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":94,"alternative-id":["10.3389\/fneur.2025.1659264"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1659264","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"article-number":"1659264"}}